15
Participants
Start Date
September 30, 2014
Primary Completion Date
April 16, 2018
Study Completion Date
September 7, 2018
baltaleucel-T
Autologous EBV-specific T-cells
The Ohio State University Comprehensive Cancer Center, Columbus
Mayo Clinic, Rochester
Centre Hospitalier de Lyon, Pierre-Bénite
Universitaire Ouest, Paris
Baylor College of Medicine, Houston
MD Anderson Cancer Center, Houston
Dana-Farber Cancer Center, Boston
Samsung Medical Center, Seoul
Asan Cancer Center, Seoul
University College London Hospital, London
The Christie Clinic, Manchester
Lead Sponsor
Cell Medica Ltd
INDUSTRY